Screener
Amneal Pharmaceuticals, Inc. AMRX Interest Expense
Interest Expense at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestIncomeExpenseNonoperatingNet.
The source filing: Amneal Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 5:19 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001723128-26-000031
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Other operating income | (1,298) | — | (8,239) | (5,122) |
| Operating income | 129,769 | 111,372 | 271,541 | 211,719 |
| Other (expense) income: | ||||
| Interest expense, net | (55,043) | (65,101) | (108,404) | (122,040) |
| Foreign exchange (loss) gain, net | (1,950) | 8,256 | (9,750) | 12,503 |
| Loss on refinancing | — | — | (3,510) | — |
| Increase in tax receivable agreement liability | (2,439) | (4,420) | (106) | (15,107) |
| Other income, net | 653 | 1,604 | 1,395 | 2,122 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Amneal Pharmaceuticals, Inc.'s interest expense?
- Amneal Pharmaceuticals, Inc. (AMRX) reported interest expense of -$55.04M in Q2 2026.
- How has Amneal Pharmaceuticals, Inc.'s interest expense changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s interest expense increased by 15.4% year-over-year, from -$65.1M to -$55.04M.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s interest expense?
- Over 4 years (2021 to 2025), Amneal Pharmaceuticals, Inc.'s interest expense has grown at a 15.3% compound annual growth rate (CAGR), from -$136.33M to -$241.09M.
- What does interest expense mean?
- Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.
Ask your AI about Amneal Pharmaceuticals, Inc.'s interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude